2197 — Clover Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Clover Biopharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	807	2,866	1,641	766	428
Net Total Accounts Receivable
Net Total Receivables	—	99.6	43.4	62	53.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,048	5,076	4,390	1,900	663
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	87	222	242	162	116
Net Intangible Assets
Other Long Term Assets
Total Assets	1,188	5,346	4,695	2,101	813
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	66.7	2,148	2,829	2,277	1,908
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,170	4,127	5,363	2,834	2,449
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-983	1,219	-668	-733	-1,636
Total Liabilities & Shareholders' Equity	1,188	5,346	4,695	2,101	813
Total Common Shares Outstanding